CRISPR-based functional genomics in human dendritic cells
Dendritic cells (DCs) regulate processes ranging from antitumor and antiviral immunity to host-microbe communication at mucosal surfaces. It remains difficult, however, to genetically manipulate human DCs, limiting our ability to probe how DCs elicit specific immune responses. Here, we develop a CRI...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2021-04-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/65856 |
id |
doaj-af2eea39e034442491abb1656b561b49 |
---|---|
record_format |
Article |
spelling |
doaj-af2eea39e034442491abb1656b561b492021-05-07T15:31:47ZengeLife Sciences Publications LtdeLife2050-084X2021-04-011010.7554/eLife.65856CRISPR-based functional genomics in human dendritic cellsMarco Jost0https://orcid.org/0000-0002-1369-4908Amy N Jacobson1Jeffrey A Hussmann2Giana Cirolia3Michael A Fischbach4Jonathan S Weissman5https://orcid.org/0000-0003-2445-670XDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States; Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, United States; California Institute for Quantitative Biosciences, University of California, San Francisco, San Francisco, United States; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, United StatesDepartment of Bioengineering, Stanford University, Stanford, United States; ChEM-H, Stanford University, Stanford, United StatesDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States; Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, United States; California Institute for Quantitative Biosciences, University of California, San Francisco, San Francisco, United States; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, United States; Whitehead Institute for Biomedical Research, Cambridge, United StatesChan Zuckerberg Biohub, San Francisco, United StatesDepartment of Bioengineering, Stanford University, Stanford, United States; ChEM-H, Stanford University, Stanford, United States; Chan Zuckerberg Biohub, San Francisco, United StatesDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States; Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, United States; California Institute for Quantitative Biosciences, University of California, San Francisco, San Francisco, United States; Whitehead Institute for Biomedical Research, Cambridge, United States; Department of Biology, Massachusetts Institute of Technology, Cambridge, United StatesDendritic cells (DCs) regulate processes ranging from antitumor and antiviral immunity to host-microbe communication at mucosal surfaces. It remains difficult, however, to genetically manipulate human DCs, limiting our ability to probe how DCs elicit specific immune responses. Here, we develop a CRISPR-Cas9 genome editing method for human monocyte-derived DCs (moDCs) that mediates knockouts with a median efficiency of >94% across >300 genes. Using this method, we perform genetic screens in moDCs, identifying mechanisms by which DCs tune responses to lipopolysaccharides from the human microbiome. In addition, we reveal donor-specific responses to lipopolysaccharides, underscoring the importance of assessing immune phenotypes in donor-derived cells, and identify candidate genes that control this specificity, highlighting the potential of our method to pinpoint determinants of inter-individual variation in immunity. Our work sets the stage for a systematic dissection of the immune signaling at the host-microbiome interface and for targeted engineering of DCs for neoantigen vaccination.https://elifesciences.org/articles/65856CRISPRdendritic cellsbacteroides thetaiotaomicronfunctional genomicsinter-individual variation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Marco Jost Amy N Jacobson Jeffrey A Hussmann Giana Cirolia Michael A Fischbach Jonathan S Weissman |
spellingShingle |
Marco Jost Amy N Jacobson Jeffrey A Hussmann Giana Cirolia Michael A Fischbach Jonathan S Weissman CRISPR-based functional genomics in human dendritic cells eLife CRISPR dendritic cells bacteroides thetaiotaomicron functional genomics inter-individual variation |
author_facet |
Marco Jost Amy N Jacobson Jeffrey A Hussmann Giana Cirolia Michael A Fischbach Jonathan S Weissman |
author_sort |
Marco Jost |
title |
CRISPR-based functional genomics in human dendritic cells |
title_short |
CRISPR-based functional genomics in human dendritic cells |
title_full |
CRISPR-based functional genomics in human dendritic cells |
title_fullStr |
CRISPR-based functional genomics in human dendritic cells |
title_full_unstemmed |
CRISPR-based functional genomics in human dendritic cells |
title_sort |
crispr-based functional genomics in human dendritic cells |
publisher |
eLife Sciences Publications Ltd |
series |
eLife |
issn |
2050-084X |
publishDate |
2021-04-01 |
description |
Dendritic cells (DCs) regulate processes ranging from antitumor and antiviral immunity to host-microbe communication at mucosal surfaces. It remains difficult, however, to genetically manipulate human DCs, limiting our ability to probe how DCs elicit specific immune responses. Here, we develop a CRISPR-Cas9 genome editing method for human monocyte-derived DCs (moDCs) that mediates knockouts with a median efficiency of >94% across >300 genes. Using this method, we perform genetic screens in moDCs, identifying mechanisms by which DCs tune responses to lipopolysaccharides from the human microbiome. In addition, we reveal donor-specific responses to lipopolysaccharides, underscoring the importance of assessing immune phenotypes in donor-derived cells, and identify candidate genes that control this specificity, highlighting the potential of our method to pinpoint determinants of inter-individual variation in immunity. Our work sets the stage for a systematic dissection of the immune signaling at the host-microbiome interface and for targeted engineering of DCs for neoantigen vaccination. |
topic |
CRISPR dendritic cells bacteroides thetaiotaomicron functional genomics inter-individual variation |
url |
https://elifesciences.org/articles/65856 |
work_keys_str_mv |
AT marcojost crisprbasedfunctionalgenomicsinhumandendriticcells AT amynjacobson crisprbasedfunctionalgenomicsinhumandendriticcells AT jeffreyahussmann crisprbasedfunctionalgenomicsinhumandendriticcells AT gianacirolia crisprbasedfunctionalgenomicsinhumandendriticcells AT michaelafischbach crisprbasedfunctionalgenomicsinhumandendriticcells AT jonathansweissman crisprbasedfunctionalgenomicsinhumandendriticcells |
_version_ |
1721455407081193472 |